About
This app assists anesthesiologists with pre-operative patient assessments. It allows for smart data capture, including scanning schedules, recognizing medicine bottles via OCR, and transcribing voice notes. Users can chart vitals in real-time and generate professional PDF anesthesia reports.
What's New in Anescribe
2.12
October 29, 2026
Faster web sign-in. Scan the sign-in QR code and confirm with Face ID. No extra approval screen.
Subscriptions & In-App Purchases
Monthly Subscription
Monthly
Developer apps
FAQ
What is Anescribe?
Anescribe is a medical application designed to help anesthesiologists streamline pre-operative patient assessments. It facilitates data capture, vital sign charting, and the generation of professional PDF anesthesia reports.
How does Anescribe capture patient data?
Anescribe offers smart data capture features, including scanning patient schedules, using OCR to recognize medicine bottles, capturing vitals from monitor screens, and voice transcription for hands-free note-taking.
Can Anescribe generate reports?
Yes, Anescribe can generate professional 2-page anesthesia reports. These reports include a patient summary with all collected data and a detailed anesthesia chart with a blood pressure graph.
What devices does Anescribe support?
Anescribe is available for iPhone and iPad devices, making it a portable tool for medical professionals.
What are the subscription options for Anescribe?
Anescribe offers a monthly subscription for $29.99 with a 3-day free trial, and a yearly subscription for $299.99 with a 14-day free trial.
Is Anescribe suitable for all ages?
Anescribe has an age rating of 4+, indicating it is suitable for a wide range of users, though its professional application targets adult medical practitioners.
How often is Anescribe updated?
The latest version of Anescribe is 2.12, and it was last updated on October 29, 2026. This suggests a consistent update schedule for the application.
Does Anescribe have ads?
No, Anescribe does not contain advertisements. Its monetization is based on subscription plans.
